Johnson & Johnson set to begin COVID-19 vaccine trials on children in Houston in next few weeks
Why Was Johnson & Johnson the Only Opioid Maker on Trial in Oklahoma? - The New York Times
Johnson & Johnson Covid-19 vaccine study paused due to illness
Johnson & Johnson Pauses Clinical Trials For Its Covid-19 Vaccine Over Participant's Illness – TIF
Stanford to enroll 1,000 volunteers for Johnson & Johnson coronavirus vaccine trial
Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says | CNN
J&J seeks nod for COVID-19 vaccine trial in Indian adolescents | Reuters
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
Johnson & Johnson pauses Covid vaccine trial over participant's 'unexplained illness' | Coronavirus | The Guardian
The Johnson & Johnson COVID-19 Vaccine: 9 Things You Should Know
Tryon Medical Partners Joins Johnson & Johnson COVID-19 Vaccine Study - Tryon Medical Partners
Johnson & Johnson must pay over $572 million for its role in Oklahoma opioid crisis, judge rules
State, Johnson & Johnson outline arguments in first day opioid trial | Local News | normantranscript.com
Johnson & Johnson asks Supreme Court to void $2B talc verdict
J&J's HIV vaccine fails trial in latest blow to the field | Reuters
Johnson & Johnson Ordered To Pay $572 Million In Oklahoma Opioid Lawsuit : Shots - Health News : NPR
Johnson & Johnson COVID jab safe and effective: US FDA | Coronavirus pandemic News | Al Jazeera
J&J (JNJ) Ends Large HIV Vaccine Trial in Latest Setback for Field - Bloomberg
Johnson & Johnson on Twitter: "JUST IN: #JNJ has announced the start of our Phase 3 clinical trial for our investigational #COVID19 vaccine candidate. We are fully focused on developing a safe,
J&J's One-Dose COVID-19 Vaccine Candidate Begins Phase III Trial | BioSpace
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J. - The New York Times
Johnson & Johnson expands COVID vaccine trial to include adolescents | The Hill
